← Who reports today · Health Care
CAH · Q4 FY2026
Archived report (Q4 FY2026). Latest deep dive →
Net earnings attributable to Cardinal Health, Inc.
$398M
up 66.5% y/y
Revenue
$63,672M
up 5.8% y/y
Operating earnings
$729M
up 70.3% y/y
Gross margin
$2,560M
up 16.3% y/y
The quarter in brief
Revenue grew 5.8% y/y to $63.67B, operating margin 1.1% vs 0.7%, net income $398M (+66.5% y/y).
All figures in $M.
| Line item | Amount and change |
|---|---|
| Revenue | $63,672 · +5.8% |
| Cost of products sold | $61,112 · +5.4% |
| Gross margin | $2,560 · +16.3% · 4.0% margin |
| Distribution, selling, general and administrative expenses | $1,625 · +9.5% |
| Restructuring and employee severance | $40 · +48.1% |
| Amortization and other acquisition-related costs | $121 · −9.0% |
| Acquisition-related cash and share-based compensation costs | $44 · −58.5% |
| Impairments and (gain)/loss on disposal of assets, net | $4 · −87.9% |
| Litigation /charges, net | $3 · −66.7% |
| Operating earnings | $729 · +70.3% · 1.1% margin |
| Other (income)/expense, net | $26 · −13.3% |
| Interest expense, net | $79 · +6.8% |
| Impairment of equity interest in Outcomes | $122 · vs $0 |
| Earnings before income taxes | $554 · +44.3% |
| Provision for income taxes | $154 · +9.2% · 27.8% effective rate |
| Less: Net (earnings)/loss attributable to noncontrolling interests | $2 · −50.0% |
| Net earnings attributable to Cardinal Health, Inc. | $398 · +66.5% · $1.70/sh · 0.6% margin |
Verdict: revenue grew 5.8% y/y to $63.67B, operating margin 1.1% vs 0.7%, net income $398M (+66.5% y/y).
Source and notation
Source: Cardinal Health press release, 8-K EX-99.1 of 08/11/2026 (SEC EDGAR). Every figure was matched against the income statement in the release; SEC XBRL for this quarter is not published yet, so the XBRL check is pending.
Open as an image: CAH, Q4 FY2026 (PNG) ↗ · for sharing and presentations · free to reuse, CC BY 4.0
Cite / embed this chart
Free to use in articles, research and social posts with credit to Who Reports Today and a link — licensed under CC BY 4.0 (terms).
Chart: “CAH Q4 FY2026: where the revenue went” by Who Reports Today, https://whoreportstoday.com/t/cah/q4-fy2026. Licensed under CC BY 4.0.
<figure> <a href="https://whoreportstoday.com/t/cah/q4-fy2026"><img src="https://whoreportstoday.com/t/cah/q4-fy2026/sankey.png" alt="CAH Q4 FY2026: where the revenue went" loading="lazy" style="max-width:100%;height:auto"></a> <figcaption>Source: <a href="https://whoreportstoday.com/t/cah/q4-fy2026">Who Reports Today</a>, licensed under <a href="https://creativecommons.org/licenses/by/4.0/">CC BY 4.0</a></figcaption> </figure>
https://whoreportstoday.com/t/cah/q4-fy2026/sankey.png
<a href="https://whoreportstoday.com/t/cah/q4-fy2026">CAH Q4 FY2026 earnings chart (Who Reports Today)</a>
This is an archived report: the image at this link won’t change. If you change the chart (crop, translate), say so in the credit. Company logos and trademarks are not covered by the license.
- Gross margin was 4.0% vs 3.7% a year earlier.
- Operating income was $729M, a 1.1% margin vs 0.7% a year earlier.
- The effective tax rate was 27.8% vs 36.7% a year earlier.
- Diluted EPS was $1.70 vs $1.00 a year earlier.
What distorts the picture in this report and what to watch beyond the headlines.
CAH — a healthcare services and products company that distributes branded, specialty and generic drugs and medical, surgical and laboratory supplies to pharmacies, hospitals, clinics and other providers.
It reports two segments: Pharmaceutical and Specialty Solutions, and Global Medical Products and Distribution; smaller businesses such as nuclear pharmacies, at-home supplies and OptiFreight Logistics are grouped in Other. · Source: annual report (Form 10-K, SEC)
More reports: CI · Q3 2026 · CNC · Q3 2026 · COO · Q3 FY2026 · COR · Q4 FY2026 · CRL · Q3 2026 · CVS · Q3 2026 · DGX · Q3 2026 · DHR · Q3 2026 · DVA · Q3 2026 · DXCM · Q3 2026 · all reports